Global Retinopathy of Prematurity Observatory
This study compares the cost-effectiveness of bevacizumab and ranibizumab for treatment-requiring retinopathy of prematurity using multicenter real-world clinical and economic data.
Related proposalWork remotely on agreed tasks with scientific supervision and project-specific training. The project brief confirms eligibility, workload, language, available places and access permissions.
Explore the scientific portfolio →Prepare your CV, country of residence, relevant skills, project preferences and weekly availability. Use the member or external route below and name this project in your application. Do not send identifiable patient information.
Related proposal ↗Admission does not authorize clinical intervention or access to confidential data. Before work begins, agree responsibilities, supervision, permissions, data/IP terms and contribution records. Authorship depends on qualifying work; no publication or journal acceptance is guaranteed.
Participation terms →